Navigation Links
Study finds most TV prescription drug ads minimize risk information
Date:1/3/2008

Athens, Ga. Prescription drug ads on television first hit the airwaves just over a decade ago, but a new University of Georgia study finds that most of them still do not present a fair balance of information, especially when it comes to the risk of side effects.

A team led by Wendy Macias, associate professor in the UGA Grady College of Journalism and Mass Communication, analyzed a weeks worth of direct-to-consumer ads on broadcast and cable television. The found that the average 60-second ad contained less than 8 seconds (13 percent of total ad time) of side effect disclaimers, while the average 30-second ad has less than 4.4 seconds (15 percent of total ad time) of disclaimers. Most of the 15-second ads studied devoted no time at all to disclaimers.

These ads clearly dont devote enough time to information about risk, said Macias, whose results appear in the November/December issue of the journal Health Communication. Adding to the problem is that the information is often presented in a way that people arent likely to comprehend or even pay attention to.

Macias and her team, which includes Kartik Pashupati at Southern Methodist University and Liza Lewis at The University of Texas at Austin, found that almost all of the ads disclosed side effects solely in a voice-over portion of the ad. Only 2.2 percent of ads had the disclosure in voice-over as well as in text form.

The 1997 FDA guidelines that allowed drug companies to greatly expand the scope of their direct-to-consumer advertising required the companies to present a fair balance between information about effectiveness and information about risk.

Fair balance is not defined by the FDA, so Macias created a four-tiered classification: 1.) Lawbreakers are ads that dont mention side effects at all; 2.) bare minimums are those that list side effects but spend less than 10 percent of time on risk information; 3.) the main pack includes ads that spend more than 10 percent of time on risk information, and 4.) the proactive, safety oriented approach, which gives equal treatment to both the risks and the benefits of the drug.

The researchers found that two percent of the ads studied were clear lawbreakers, 10 percent met bare minimum requirements and 88 percent were in the main pack. The researchers analyzed commercials that aired in 2003, but Macias said current ads are similar in their content and leave much to be desired.

Very few advertisers are really doing well enough when it comes to actually trying to educate the consumer, she said. The ads are presented in such a way that the consumer would have to be paying very close attention and be adept at processing the information to really understand the risks as well as the benefits.

Proponents of direct-to-consumer ads argue that they help raise awareness of various medical conditions and their treatments. Critics argue that the ads drive up health care costs by steering consumers to costly drugs that they might not need. Still, Nielsen Media Research estimates that pharmaceutical companies spent more than $1.5 billion on direct-to-consumer television ads during the first half of 2007.

Macias said most ads could clearly do more to educate consumers, and points to recent advertisements for Johnson and Johnsons Ortho Evra birth control patch that give equal emphasis to the risks and benefits of the drug as an example of a more balanced approach.

A prescription drug is something that consumers should be making a rational decision about, Macias said. And the more information consumers have, the better decisions they can make.


'/>"/>

Contact: Sam Fahmy
sfahmy@uga.edu
706-542-5361
University of Georgia
Source:Eurekalert

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data derived ... Assessment of major trends with potential impact on the market ... of market segmentation which comprises of sub markets, regional and ...
Breaking Medicine Technology: